FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Mallinckrodt Pays $100 Million in Antitrust Settlement

Mallinckrodt agrees to pay $100 million to settle Federal Trade Commission charges that it violated antitrust laws when its subsidiary Questcor acquir...

Federal Register

Draft Guide on Biosimilar Interchangeability

Federal Register Notice: FDA makes available a draft guidance for industry entitled Considerations in Demonstrating Interchangeability With a Referenc...

Federal Register

Guidance on Assessing Abuse Potential Drugs

Federal Register Notice: FDA makes available a guidance entitled Assessment of Abuse Potential of Drugs.

Federal Register

Symmetrel Not Withdrawn for Safety/Efficacy Reasons

Federal Register Notice: FDA determines that Endo Pharmaceuticals Parkinsons drug Symmetrel (amantadine hydrochloride), syrup, 50 milligrams/5 millili...

Human Drugs

Rethink Orphan Drug Incentives: Waxman

Former Rep. Henry Waxman says some orphan drug financial incentives may no longer be needed because some companies are gaming the system to use them t...

FDA General

Califf Discusses Needed Changes With Advisory Committees

FDA commissioner Robert Califf says advisory committees are of questionable value in their current form and the agency is evaluating needed changes to...

Human Drugs

Lilly Forteo Petition Denied

FDA denies as premature a Lilly request that it revise the definition of biological product to include Forteo and not approve any ANDA referencing For...

FDA Outlines 1st Amendment Issues in Manufacturer Speech

FDA provides a legal memorandum on its approach to manufacturer communication about unapproved uses of drugs and medical devices within the context of...

New Final Rule for Research Participant Protection

FDA, HHS, and other federal agencies issue a new research patient protection final rule with most provisions taking effect in 2018.

Human Drugs

Some Tweeting Docs Have Industry Ties: Study

Modern Healthcare says that a small JAMA Internal Medicine study demonstrates that many hematologists/oncologists who reach cancer patients by tweetin...